Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/ below:

Cancer Waiting Times

Following a consultation on the cancer waiting times standards, NHS England have had approval from government to implement changes to the standards from 1 October 2023.

The response to the consultation is published here NHS England » Cancer waiting times review – Models of care and measurement: consultation response

The statistics on cancer waiting times will be updated to ensure that they follow the changed operating framework for cancer, and address responses to the consultation on disaggregation of the standards.  These changes will begin from the publication of October 2023 data planned to be published in December 2023.  The updates are as follows:

• • Outputs to give prominence to the headline statistics for the new waiting times standards.
  • Maintain the statistics published on the 28 day Faster Diagnosis Standard.
  • Include breakdowns of the new 31 and 62 day standards by variables which allow derivation of the old 31 and 62 day standards.  That is, for the 31 day standard include breakdowns by treatment stage (first or subsequent) and modality (Anti-cancer drug regimen, Radiotherapy, Surgery, Other), and for the 62 day standard by source of referral (Urgent suspected cancer, Breast Symptomatic, Screening and Consultant Upgrade).
  • Remove the breakdown by admitted and non admitted care from treatment standards.
  • For the 31 and 62 day standards, provide a more granular tumour type breakdown for a range of cancers by sub dividing the categories currently published.  Historic data for the new categories will not be available.  The new classification will be such that the old classification for the current 31 first and 62 day urgent suspected cancer will be able to be derived from aggregation of the new categories to create a consistent time series.  That is, adopt the following new categories: Lung, Breast, Skin, Lower GI, Prostate, Other Urological, Lymphoma, Other haematological, OG, Hepatobiliary, Head and Neck, Gynaecological and ‘All Other’ cancers.
  • 31-day referral to treatment performance for acute leukaemia, children’s and testicular cancers will no longer be published separately, as no performance standard has been applied to this report for some time and reported numbers are extremely small. Data for these cancers will continue to be included within the wider 62-day referral to treatment data.
  • Continue to publish total numbers seen following an urgent suspected cancer referral and urgent referral where breast symptoms are exhibited but cancer is not initially suspected. Maintain the time waited bands as currently published for these measures, but cease publication of the % seen within 14 days which was the two week wait performance measure which is being removed from the operating framework.
  • Publish further management information on the backlog.

NHS England will initially adopt an official statistics badge for all the updated statistical outputs, pending assessment by the Office for Statistics Regulation.

Feedback can be sent through to england.cancerwaitsdata@nhs.net

The following reports provide information on the waiting times of people referred with suspected cancer or breast symptoms and subsequently told the outcome of their diagnosis, and treated for cancer by the NHS in England.

From the 14th December 2023, cancer waiting times statistics have been updated to reflect the new operating framework for October 2023 data onwards.

The latest data is available here: Monthly data and summaries

CWT CRS – National Time Series Oct 2009 – Feb 2025 with Revisions (XLSX, 56KB)
CWT CRS – Provider Time Series Apr 2021 – Feb 2025 with Revisions (XLSX, 569KB)
CWT CRS – Commissioner Time Series Jul 2022 – Feb 2025 with Revisions (XLSX, 154KB)

CWT CRS – National Time Series Oct 2009 – Feb 2025 Provisional (XLSX, 48KB)
CWT CRS – Provider Time Series Apr 2021 – Feb 2025 Provisional (XLSX, 543KB)
CWT CRS – Commissioner Time Series Jul 2022 – Feb 2025 Provisional (XLSX, 154KB)

The following files provide data by month from April 2022 to the most recent available data. These files provide levels of activity by standard, by provider or ICB sub location, and for the provider based data by cancer type.

The provider extract adopts a consistent breakdown for the provider workbooks. For the 31 day combined standard, stage is available in combination with modality or cancer type, whilst modality by cancer type is not available. For the 62 day combined standard, route is available by modality or cancer type, whilst modality by cancer type is not available.

‘Cancer Type’ (for the 31 and 62 day combined standards) is based on a higher granularity from April 2022 to September 2023, than for October 2023 data onwards. Data for April 2023-September 2023 are given in a separate data file than data for October 2023 onwards. A technical explanation of the tumour classification adopted is available here: Technical note on tumour classifications in 31 and 62 day combined standards

CWT CRS Oct 2024 to Feb 2025 Data Extract (Provider) (XLSX, 1.8MB)
CWT CRS Apr 2024 to Sep 2024 Data Extract (Provider) Final (XLSX, 2.19MB)
CWT CRS Oct 2023 to Mar 2024 Data Extract (Provider) Final (XLSX, 2.7MB)
CWT CRS Apr 2023 to Sep 2023 Data Extract (Provider) Final (XLSX, 2.2MB)
CWT CRS 2022-23 Data Extract (Provider) Final (XLSX, 4.9MB)

The ICB Sub location extract gives data by standard and a limited set of sub categories, this is by stage and modality for the 31 day combined standard, and by route for the 62 day combined standard.

CWT CRS Oct-24 to Feb-25 Data Extract (ICB Sub Location) (XLSX, 192KB)
CWT CRS Apr-24 to Sep-24 Data Extract (ICB Sub Location) Final (XLSX, 229KB)
CWT CRS Apr-23 to Mar-24 Data Extract (ICB Sub Location) Final (XLSX, 434KB)
CWT CRS Jul-22 to Mar-23 Data Extract (ICB Sub Location) Final (XLSX, 400KB)

Published data on the cancer waiting times standards in place to September 2023 are available here: Cancer Waiting Times standards to September 2023

From July 2022 cancer waiting times commissioner data is published by Integrated Care Boards in the main publication outputs. Information by Sub ICB Location is available as a long thin data table in the Data extracts (Monthly commissioner based only) section below.

The national levels of activity and performance of commissioner-based statistics on waiting times for suspected and diagnosed cancer patients may differ from the equivalent provider-based national statistics on cancer waiting times.

This is because the commissioner-based statistics only include those patients who can be traced back to an English commissioner using their NHS Number. As a result, the national calculated performance levels may differ slightly between the two datasets.

As the commissioner (Clinical Commissioning Groups and from July 2022 Integrated Care Boards) based statistics are derived from those data submitted by the providers of NHS cancer services, the provider-based National Statistics on waiting times for suspected and diagnosed cancer patients (published at the same time as these statistics) remain the most complete assessment of the performance of the English NHS.

To March 2019 the allocation was equally divided between first seen and treatment providers.

From April 2019 the allocation of patients on 62 day pathways which involve multiple providers was changed and the rules set out in the national cancer waiting times monitoring dataset guidance, the latest version of which can be found here: Cancer Waiting Times Data Collection (CWT) – NHS Digital

The example document Technical Annex – Patient Allocation (XLSX,48KB) accompanying the publication of April 2019 data shows the impact of this change at the provider level in April 2019. The national figures are unaffected by this change.

For data to March 2018 / Quarter 4 2017/18, monthly cancer waiting times data was classed as provisional and quarterly data classed as final, therefore the sum of the standalone months in a quarter do not necessarily match the standalone quarterly data.

From April 2018 / Quarter 1 2018/19 onwards, monthly and quarterly data are synchronized. Both monthly and quarterly data are first released as provisional data, and subsequently finalised in line with the NHS England revisions policy. Each year, there are two revisions to cover from April to September data (the earliest these would be published is in January), and from October to March data (the earliest these would be published is in July).

Please see note below on the publication of data from August 2019 onwards. Reporting for all providers and commissioners resumed from July 2022 data.

Publication of Cancer Waiting Times data CRS-15 April 2021

The 28-Day Faster Diagnosis Standard are published from April 2021 data in June 2021.

Please visit Cancer Waiting Times section on the NHS Digital website.

Weekly management information on the cancer 62 day backlog for NHS acute providers is available here: MI on cancer

For further information about the published statistics, please contact us at:

Cancer Waiting Times Team
NHS England
7 & 8 Wellington Place
Leeds
LS1 4AP
Great Britain
Email: england.cancerwaitsdata@nhs.net

Alternatively, if you are a patient or carer wishing to discuss your experience of waiting times, you should contact your local commissioner, which you can find elsewhere on the NHS England website.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3